Individualized treatment of patients with non‑small cell lung cancer

04/2018

MUDr. Jaromír Roubec, Ph.D.

Komplexní onkologické centrum Nový Jičín, Plicní oddělení, Vítkovická nemocnice a.s.

SUMMARY

Author in this article describes crucial periods and changes in the attitude to the therapy of the local progressive and metastatic bronchogenic carcinoma during the last three decades with the accent on the rapid progress in the personalized target therapy and immunotherapy of this disease together with next perspectives in the research and clinical practice.

KEY WORDS

bronchogenic carcinoma, individualized target biologic therapy, immunotherapy